Sartorius Stedim Biotech and Novasep collaborate on membrane chromatography

Sartorius Australia Pty Ltd

Friday, 08 March, 2019

Sartorius Stedim Biotech (SSB) and Novasep, providers for the biopharmaceutical and life science industries, respectively, have entered into a collaboration agreement in the area of chromatography and single-use bioprocessing.

Novasep is a recognised system provider with substantial expertise in the design, manufacture and control of resin-based batch and continuous chromatography systems. Systems designed for membrane chromatography applications are a part of SSB’s global product strategy to supply complete solutions for upstream and downstream processing in life sciences. With this in mind, Novasep’s established BioSC platform and SSB’s single-use technology will form the basis of innovative chromatography systems.

Systems currently on the market are designed for resins, but do not take full advantage of membrane chromatography capabilities. Optimally run membrane chromatography processes should provide a good alternative to batch and continuous resin-based chromatography, with higher productivity, smaller scale operations and increased robustness.

“Membranes are the embodiment of process intensification,” said Dr Fritjof Linz, Head of Separation at Sartorius Stedim Biotech. “As the market leader in membrane chromatography, Sartorius Stedim Biotech aims to realise this potential and offer customers the full benefits of our Sartobind portfolio. We are happy to work with a highly competent partner like Novasep to introduce new membrane chromatography technology for flow through and capture applications.”

Nadège Laborde, President Process Solutions at Novasep, added, “This collaboration is a wonderful opportunity for Novasep and Sartorius Stedim Biotech, as it leverages the core capabilities of the two companies. The result of this venture will satisfy the latest market demands for continuous processing, process intensification, performance and ease of use.”

Please follow us and share on Twitter and Facebook. You can also subscribe for FREE to our weekly newsletters and bimonthly magazine.

Related News

Updated standard to reduce errors in medical laboratories

ISO 22367 specifies a process for a medical laboratory to identify and manage the risk to...

NHMRC presents 2019 Research Excellence Awards

Research Excellence Awards are awarded each year to top-ranked researchers and teams following...

Thermo Fisher announces new appointment, QIAGEN acquisition

Thermo Fisher Scientific has proposed to acquire QIAGEN and appointed Paul G Parker as Senior...

  • All content Copyright © 2020 Westwick-Farrow Pty Ltd